✦ LIBER ✦

P993 EASL AND MRECIST RESPONSE TO COMBINATION THERAPY OF SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION PREDICTS SURVIVAL IN HEPATOCELLULAR CARCINOMA

✍ Scribed by Wang, W.; Bai, W.; Zhao, Y.; Yin, Z.; He, C.; Niu, J.; Liu, L.; Chen, H.; Fan, D.; Han, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to: “Do EASL and mRECIST responses

✍ Tim Meyer; Amy Kirkwood; Roopinder Gillmore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 276 KB

639 SINGLE NUCLEOTIDE POLYMORPHISM ASSOC

✍ J.-H. Lee; Y.-H. Chung; J.A. Kim; E.-S. Shin; D. Lee; J.H. Shim; H.C. Lee; J.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Abstract No. 219: Correlation of surviva

✍ Prajapati, H.J.; Chen, Z.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB

261 VASCULAR ENDOTHELIAL GROWTH FACTOR A

✍ Lee, D.; Chung, Y.-H.; Kim, J.A.; Lee, J.-H.; Shin, E.-S.; Shim, J.-H.; Lee, H.C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Combination Therapy of Radiofrequency Ab

✍ C.L. Marshall; S.T. Orcutt; C.N. Robinson; C.J. Balentine; C. Bechara; P. Kougia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Sorafenib in combination with transarter

✍ Feng DUAN; Mao Qiang WANG; Feng Yong LIU; Zhi Jun WANG; Peng SONG; Yan WANG 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB